Interlaboratory variation in molecular testing for EGFR, KRAS and ALK in stage IV non-squamous non-small cell lung cancer in The Netherlands in 2013

被引：0
|
作者：
Kuijpers, C. [1 ]
Overbeek, L. [1 ]
Rotteveel, S. [1 ]
van Ommen, R. [1 ]
Koole, K. [1 ]
van Slooten, H. -J. [1 ]
van den Heuvel, M. [1 ]
Damhuis, R. [1 ]
Willems, S. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
来源：
VIRCHOWS ARCHIV | 2016年 / 469卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-22-009
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [1] Interlaboratory Variation in Molecular Testing (EGFR, KRAS and ALK) in Stage IV Non-Squamous Non-Small Cell Lung Cancer in the Netherlands in 2013
    Kuijpers, Chantal
    Overbeek, Lucy
    Rottevee, Sandra
    Van Ommen, Rene
    Koole, Koos
    Van Slooten, Henk-Jan
    Van den Heuvel, Michel
    Damhuis, Ronald
    Willems, Stefan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S489 - S490
  • [2] Reflex Testing of EGFR and ALK in Non-Squamous Non-Small Cell Lung Cancer
    Tan, Jonan Z. -E.
    Ong, Whee-Sze
    Tan, Daniel S. -W.
    Takano, Angela
    Lim, Tony Kiat-Hon
    Chan, Kian-Sing
    Oon, Lynette Lin-Ean
    Lim, Alvin Soon-Tiong
    Jain, Amit
    Toh, Chee-Keong
    Ang, Mei-Kim
    Ng, Quan-Sing
    Kanesvaran, Ravindran
    Devanand, Anantham
    Lim, Chong-Hee
    Koh, Tina Puay-Theng
    Lim, Wan-Teck
    Tan, Eng Huat
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S698 - S699
  • [3] KRAS molecular profiling in non-squamous non-small cell lung cancer (NSCLC).
    Karim, Nagla Abdel
    Starnes, Sandra
    Morris, John
    Pathrose, Peter
    Perry, Ashley
    Fathallah, Hassana
    [J]. CLINICAL CANCER RESEARCH, 2014, 20
  • [4] Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
    Yanhui Wan
    Youhui Qian
    Youyu Wang
    Fuyuan Fang
    Guodong Wu
    [J]. Discover Oncology, 13
  • [5] Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
    Wan, Yanhui
    Qian, Youhui
    Wang, Youyu
    Fang, Fuyuan
    Wu, Guodong
    [J]. DISCOVER ONCOLOGY, 2022, 13 (01)
  • [6] Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).
    Karim, N.
    Pathrose, J.
    Fathallah, H.
    El Desouki, I.
    Perry, A.
    Starnes, S.
    Morris, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S714 - S715
  • [7] Impact of reflex testing for EGFR mutations in non-squamous non-small cell lung cancer (NSCLC).
    Cheema, Parneet Kaur
    Victor, Charles
    Dolley, Aastha
    Dziarmaga, Alison
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer
    Kuijpers, C. C. H. J.
    Hendriks, L. E. L.
    Derks, J. L.
    Dingemans, A-M. C.
    van Lindert, A. S. R.
    van den Heuvel, M. M.
    Damhuis, R. A.
    Willems, S. M.
    [J]. LUNG CANCER, 2018, 121 : 76 - 81
  • [9] MOLECULAR TESTING IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER AND THE ROLE OF LIQUID CYTOLOGY SPECIMENS
    Moore, S.
    Loff, K.
    Murphy, M.
    [J]. RESPIROLOGY, 2020, 25 : 60 - 60
  • [10] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
12345